Related Experiment Videos
[Pulmonary thromboembolism accompanied by abnormal plasminogen].
Y Shinozawa1, J J Sim, M Hoshino
1Second Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
Summary
A rare case of pulmonary thromboembolism was diagnosed in a patient with abnormal plasminogen, a genetic condition. This finding suggests a potential link between plasminogen gene mutations and thromboembolic events.
Area of Science:
- Cardiology
- Genetics
- Pulmonology
Background:
- Pulmonary thromboembolism (PTE) is a serious condition often linked to acquired risk factors.
- Genetic predispositions to thromboembolism are increasingly recognized.
- Plasminogen, a key protein in fibrinolysis, plays a crucial role in preventing blood clots.
Observation:
- A 38-year-old male presented with acute chest pain and bloody sputum.
- Diagnostic imaging revealed segmental defects in lung perfusion and a filling defect in the pulmonary artery, confirming PTE.
- Low serum plasminogen activity was identified in the patient and his family members.
Findings:
- Genetic analysis identified a point mutation in the plasminogen gene (PLG) in the affected family.
- This mutation suggests an underlying genetic abnormality in plasminogen function.
- While abnormal plasminogen is common in Japan, symptomatic thromboembolism associated with it is exceptionally rare.
Implications:
- This case highlights a rare association between genetic plasminogen abnormalities and pulmonary thromboembolism.
- Further research is warranted to understand the specific mechanisms linking plasminogen gene mutations to thrombotic events.
- Investigating plasminogen function may be important in evaluating patients with unexplained or familial thromboembolism.